The provided company description is unavailable or incomplete and does not allow for a proper introduction.
An insightful summary requires basic information about the firm's operations and sector.
Updated: February 15, 2026, 16:00 EST
Technical Perspective NBIS exhibits high volatility and clear negative momentum, significantly underperforming the market over recent months. While it trades well above its 52-week low, its substantial decline from peaks suggests near-term instability. Investors should remain cautious given the persistent downward trend and lack of clear technical support levels.
Fundamental Assessment The company faces severe profitability challenges, with high revenue failing to translate into positive earnings due to elevated operating expenses. Although liquidity is adequate, negative cash conversion and poor operational efficiency indicate underlying weaknesses in execution and capital management. These factors highlight considerable operational and financial risks.
Valuation & Risk Outlook Valuation metrics point to extreme overvaluation, with a TTM P/E of over 800 and negative forward earnings signaling misalignment with fundamentals. The stock's high volatility and significant drawdown history further elevate downside risks, despite the absence of pronounced short interest.
NBIS currently presents substantial risks with weak profitability, inefficient operations, and unsupportive valuation levels. The persistent negative momentum and high volatility further discourage near-term entry. Given these challenges, the stock is not recommended for purchase at this time. Investors should monitor for signs of operational improvement and valuation normalization before considering a position.
Based on the provided analysis, the 12-month outlook for NBIS is highly cautious.
Key negative catalysts include the urgent need for the company to demonstrate a credible path to profitability by significantly controlling operating expenses and improving its negative cash conversion. A potential positive catalyst would be any concrete sign of operational improvement or a strategic shift that addresses its fundamental weaknesses. The primary risks are substantial, centered on its extreme overvaluation relative to negative earnings, persistent operational inefficiency, and the high volatility that could lead to further sharp declines in the absence of technical support. Given the lack of a positive analyst target and the concerning fundamentals, a conservative target price range is difficult to establish, with the risk skewed heavily toward a re-rating to lower valuation levels.
Most Wall Street analysts are optimistic about Nebius Group N.V.'s 12-month outlook, with consensus target around $98.01, indicating expected upside potential.
Overall, NBIS has investment potential but also faces challenges. Here are key factors to weigh before investing.
NBIS has demonstrated significant volatility over the past year, experiencing a substantial decline from its peak despite trading well above its 52-week low.
The stock has underperformed considerably in the short term, with a -10.86% decline over three months that significantly trails the broader market by -10.91%. This recent weakness follows a -3.89% decline over the past month, indicating persistent negative momentum.
Currently trading at $98.01, NBIS sits in the upper-mid range of its 52-week high-low spectrum, approximately 30% below its peak but over 435% above its low. While the substantial distance from the high suggests the stock is not overbought, the extreme volatility and recent underperformance warrant caution regarding its near-term stability.
| Period | NBIS Return | S&P 500 |
|---|---|---|
| 1m | -3.9% | -1.2% |
| 3m | -10.9% | +0.1% |
| 6m | +50.1% | +7.8% |
| 1y | +103.9% | +11.5% |
| ytd | +9.0% | -0.2% |
Revenue & Profitability NBIS shows concerning profitability trends despite generating substantial quarterly revenues ($227.7M in Q4 2025). The company maintains a strong gross margin near 70%, but operating expenses are consuming all gross profit, resulting in negative operating margins (-103% in Q4) and significant net losses (-$249.6M). The large negative EBITDA margin (-23.6%) indicates fundamental operational challenges despite healthy top-line revenue generation.
Financial Health The company maintains reasonable liquidity with current and quick ratios above 3.0, supported by strong cash balances. However, the negative cash conversion cycle (-1,305 days) suggests extended payment terms with suppliers, which may mask underlying cash flow pressures. While the debt ratio is manageable at 39%, the negative interest coverage and cash flow to debt ratio (0.17) indicate potential challenges in servicing obligations from current operations.
Operational Efficiency Operational efficiency appears challenged with very low asset turnover (0.018) and negative returns on both assets (-2.0%) and equity (-5.4%). The extended days sales outstanding (285 days) points to inefficient collections, compounding operational weaknesses. These metrics collectively suggest inefficient capital utilization and operational execution despite the company's revenue scale.
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Try Now & Get Tesla Stock RewardValuation Level The stock's TTM PE ratio of 816.75 is exceptionally high and indicates severe overvaluation relative to historical standards and earnings capacity. A negative forward PE and negative EV/EBITDA further signal that market expectations are disconnected from current and projected profitability, reflecting significant pricing risks.
Peer Comparison Due to the unavailability of industry average data, a comparative assessment cannot be conducted. However, metrics such as negative forward earnings and EV/EBITDA strongly suggest the company is an outlier, likely underperforming typical valuation benchmarks within its sector.
Volatility Risk: With a beta of 1.154, NBIS is expected to be slightly more volatile than the broader market, indicating a moderate level of systematic risk. This is compounded by a severe 1-year maximum drawdown of -58.27%, which highlights the stock's significant potential for substantial peak-to-trough losses and high downside volatility.
Other Risks: The absence of any reported short interest suggests there is minimal active betting against the stock, which can be interpreted as a lack of strong negative sentiment from sophisticated investors. However, this lack of short interest should be considered alongside other metrics like liquidity, which is not provided but could pose risks if trading volume is low and bid-ask spreads are wide.
Based on the analysis presented, I would take a neutral to bearish stance on NBIS.
The stock appears significantly overvalued with a staggering TTM P/E of over 800 and negative operating profitability, suggesting the current price is not justified by fundamentals. While explosive revenue growth and positive analyst sentiment are compelling, these are overshadowed by persistent net losses, weak operational efficiency, and high downside volatility.
This stock may only suit highly risk-tolerant, speculative investors betting on a long-term AI growth story, while value and stability-focused investors should avoid it.
Based on the provided data, NBIS appears significantly overvalued. The stock's extreme valuation multiples - particularly a TTM PE of 816.75 and a PS ratio of 88.65 - are extraordinarily high compared to normal market standards. These metrics are especially concerning given the company's fundamental weaknesses, including negative profitability, negative operating margins, and inefficient capital utilization. The disconnect between these inflated valuation metrics and the poor operational performance creates substantial downside risk for investors.
Based on the provided information, here are the key risks of holding NBIS stock, ordered by importance:
1. Fundamental Profitability Risk: The company has a significant fundamental flaw as high operating expenses cause substantial net losses (-$249.6M) and negative operating margins (-103%), indicating the core business model is currently unsustainable despite generating revenue. 2. Severe Price Volatility Risk: The stock exhibits extreme downside volatility, evidenced by a severe 1-year maximum drawdown of -58.27%, meaning shareholders are exposed to the risk of rapid and major losses in value. 3. Operational and Cash Flow Risk: Critical operational inefficiencies, including an extremely negative cash conversion cycle (-1,305 days) and very high days sales outstanding (285 days), create significant risk of underlying cash flow strain and an inability to effectively manage working capital.
Based on the provided analysis, the forecast for NBIS to 2026 is highly pessimistic. A credible base case target price range is difficult to establish as further downside is more probable than a recovery, while a bull case of $120-$150 would require a complete operational turnaround that currently lacks evidence. Key assumptions are that the company's fundamental inefficiencies—specifically its inability to control operating expenses and its negative cash conversion cycle—persist, preventing a path to profitability. This forecast carries extreme uncertainty, as the stock's performance is entirely dependent on whether management can execute a radical strategic shift to address its deep-seated operational flaws.